topiramate with semaglutide Wegovy Weight Loss Pill: How

The agency's Adverse Event Reporting System (FAERS) continuously collects reports of adverse events, including cancer diagnoses, among patients using these medications, though such reports do not establish causation

The latest research from Numerator shows that 70% of individuals who anticipate using GLP-1 medications in the future say theyll be doing so for weight loss and not for diabetes, up from 34% of current users

the trial design largely excluded these agents, which is an important consideration when interpreting the hypoglycaemia data

Therefore, extra thyroid imaging or monitoring beyond standard clinical guidelines isnt typically needed just because youre taking these drugs [5011]